Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | STP707 |
| Trade Name | |
| Synonyms | STP-707|STP 707 |
| Drug Descriptions |
STP707 is a siRNA-based polypeptide nanoparticle consisting of siRNAs that target TGF-beta 1 and COX-2, leading to decreased TGF-beta 1 and COX-2 signaling, potentially resulting in enhanced antitumor immune response and decreased tumor growth (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C184380 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| STP707 | STP707 | 0 | 1 |